01 1Emcure Pharmaceuticals Limited
02 1Siegfried AG
01 1Trimethobenzamide HCl
02 1Trimethobenzamide hydrochloride
01 1India
02 1Switzerland
TRIMETHOBENZAMIDE HYDROCHLORIDE
NDC Package Code : 14593-884
Start Marketing Date : 2020-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
TRIMETHOBENZAMIDE HYDROCHLORIDE
NDC Package Code : 17205-416
Start Marketing Date : 1981-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
53
PharmaCompass offers a list of Trimethobenzamide HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trimethobenzamide HCl manufacturer or Trimethobenzamide HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimethobenzamide HCl manufacturer or Trimethobenzamide HCl supplier.
PharmaCompass also assists you with knowing the Trimethobenzamide HCl API Price utilized in the formulation of products. Trimethobenzamide HCl API Price is not always fixed or binding as the Trimethobenzamide HCl Price is obtained through a variety of data sources. The Trimethobenzamide HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI), including repackagers and relabelers. The FDA regulates Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) supplier is an individual or a company that provides Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) active pharmaceutical ingredient (API) or Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) finished formulations upon request. The Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) suppliers may include Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) API manufacturers, exporters, distributors and traders.
click here to find a list of Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI) suppliers with NDC on PharmaCompass.
We have 2 companies offering Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI)
Get in contact with the supplier of your choice:
